By R. Chadwick Paul, Jr., President and CEO
For more than 18 years, I have had the privilege of leading the Ben Franklin Technology Partners of Northeastern Pennsylvania. Along the way, we have mentored and supported a variety of companies in many different technology and manufacturing sectors. Several of these companies have gone on to significantly impact their respective industries and address crucial societal problems, such as the COVID-19 pandemic.
US Specialty Formulations, LLC., founded by Kyle Flanigan, PhD, is a Current Good Manufacturing Practice (cGMP) manufacturer of sterile injectable pharmaceuticals used by healthcare providers or in new drug or vaccine clinical trials. Millions of Americans require specialized and custom-manufactured drugs. These specially prepared drugs are U.S. Food & Drug Administration (FDA)-approved medications and are marketed globally.
USSF teamed with another Ben Franklin founder, Garry Morefield, PhD, VaxForm LLC, and recently announced positive pre-clinical results in its joint development program to bring oral COVID-19 and other vaccines to market in 2021.
Read More